Short interest in Akebia Therapeutics Inc (NASDAQ:AKBA) decreased during the last reporting period, falling from 17.99M to 14.45M. This put 6.69% of the company's publicly available shares short.

Short interest for Akebia Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Akebia Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.70M shares traded per day, it would take 5.36 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.